Cutler Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-800
Closed -$69K 3801
2023
Q2
$69K Hold
800
0.01% 1121
2023
Q1
$77K Sell
800
-1,349
-63% -$140K 0.01% 1116
2022
Q4
$222K Buy
+2,149
New +$202K 0.02% 742
2022
Q3
Sell
-2,087
Closed -$186K 4920
2022
Q2
$172K Buy
+2,087
New +$166K 0.01% 1098
2021
Q4
Sell
-2,170
Closed -$179K 5391
2021
Q3
$167K Sell
2,170
-300
-12% -$23.7K 0.01% 1497
2021
Q2
$206K Buy
2,470
+2,370
+2,370% +$188K 0.01% 1324
2021
Q1
$7K Sell
100
-5,426
-98% -$443K ﹤0.01% 4079
2020
Q4
$484K Buy
5,526
+4,326
+361% +$343K 0.02% 644
2020
Q3
$91K Buy
+1,200
New +$121K 0.01% 1371
2020
Q2
Sell
-2,000
Closed -$199K 4389
2020
Q1
$169K Buy
2,000
+100
+5% +$8.62K 0.01% 1059
2019
Q4
$160K Buy
1,900
+1,800
+1,800% +$136K 0.01% 939
2019
Q3
$6K Sell
100
-6,800
-99% -$524K ﹤0.01% 2893
2019
Q2
$590K Buy
6,900
+4,550
+194% +$389K 0.05% 311
2019
Q1
$208K Sell
2,350
-18,184
-89% -$1.69M 0.02% 629
2018
Q4
$1.75M Buy
20,534
+9,348
+84% +$889K 0.17% 97
2018
Q3
$1.08M Buy
11,186
+3,628
+48% +$362K 0.08% 243
2018
Q2
$711K Buy
7,558
+972
+15% +$85.1K 0.06% 341
2018
Q1
$533K Sell
6,586
-5,987
-48% -$514K 0.05% 396
2017
Q4
$1.12M Sell
12,573
-545
-4% -$47.4K 0.05% 301
2017
Q3
$1.22M Buy
13,118
+6,923
+112% +$612K 0.05% 294
2017
Q2
$562K Sell
6,195
-16,102
-72% -$1.46M 0.02% 631
2017
Q1
$1.96M Buy
22,297
+11,850
+113% +$1.05M 0.08% 211
2016
Q4
$865K Sell
10,447
-19,409
-65% -$1.67M 0.03% 461
2016
Q3
$2.76M Buy
29,856
+15,440
+107% +$1.45M 0.12% 123
2016
Q2
$1.12M Sell
14,416
-3,333
-19% -$283K 0.06% 266
2016
Q1
$1.46M Buy
17,749
+14,894
+522% +$1.21M 0.1% 177
2015
Q4
$299K Buy
+2,855
New +$298K 0.02% 887

Other funds holding BMRN